Viking Global Investors: A Connecticut-based American hedge fund specializing in venture stages.
323
Operating
1999
Greenwich, CT, US
Viking Global Investors is a Connecticut-based hedge fund specializing in venture capital investments across various stages. The firm demonstrates a diverse investment approach, participating in funding rounds from seed to late-stage, with a particular focus on Series A to Series E rounds. Viking Global Investors typically invests in innovative companies across multiple sectors, including biotechnology, healthcare, technology, and consumer goods.
Notable portfolio companies include Moderna, Ginkgo Bioworks, Impossible Foods, and Roivant Sciences. Viking Global Investors has supported numerous high-profile startups that have gone on to achieve significant success and valuations. The firm's investment strategy appears to prioritize companies with disruptive technologies and potential for substantial growth, particularly in the life sciences and technology sectors.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies77
Follow-on Investments57
Current Portfolio Count63
Total Portfolio Exits10
Top Investment Stages
Series A26 (26.0%)
Series B25 (25.0%)
Series C18 (18.0%)
Series D18 (18.0%)
Series E13 (13.0%)
Stage Mix
Series A 26%Series B 25%Series C 18%Series D 18%Series E 13%
Concentration shown as share of disclosed investments by stage.